PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsMk0518
Mk0518
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
333 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hiv infectionsD015658EFO_0000764B202947604866237
HivD006678—O98.711810232272
Acquired immunodeficiency syndromeD000163EFO_0000765B2041214111654
InfectionsD007239EFO_0000544—691341444
Communicable diseasesD003141——4482925
Hepatitis cD006526—B19.26435117
Immunologic deficiency syndromesD007153—D84.91553315
HepatitisD006505—K75.95434115
Healthy volunteers/patients———8——2212
Hepatitis aD006506EFO_0007305B153332110
Show 24 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ViremiaD014766—B34.9—11—13
Liver cirrhosisD008103EFO_0001422K74.0121——3
FibrosisD005355——121——3
Virus diseasesD014777—B34—12—13
PregnancyD011247EFO_0002950Z33.1—21—13
Renal insufficiencyD051437—N19—11——2
Chronic hepatitisD006521—K73.9—11——1
Chronic renal insufficiencyD051436—N18——1——1
Treatment-resistant depressive disorderD061218————1——1
HyperlipidemiasD006949EFO_0003774E78.5——1——1
Show 2 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Adult t-cell leukemia-lymphomaD015459—C91.512———2
T-cell leukemiaD015458——12———2
Highly active antiretroviral therapyD023241———1——12
LipodystrophyD008060—E88.1—1——12
LeukemiaD007938—C9511———1
LymphomaD008223—C85.911———1
Liver diseasesD008107EFO_0001421K70-K7711———1
End stage liver diseaseD058625EFO_1001311K72.111———1
Liver failureD017093—K72.911———1
Biliary liver cirrhosisD008105—K74.3—1———1
Show 5 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
DepressionD003863—F33.92———13
Htlv-i infectionsD015490EFO_0007316—2————2
HepacivirusD016174——1————1
Head and neck neoplasmsD006258——1————1
Squamous cell carcinomaD002294——1————1
Insulin resistanceD007333EFO_0002614E88.8191————1
Muscle spasticityD009128——1————1
Tropical spastic paraparesisD015493EFO_0007527G04.11————1
ParaparesisD020335—G82.21————1
Spastic paraparesisD020336——1————1
Show 4 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Chronic hepatitis bD019694EFO_0004239B18.1————11
Female genital diseasesD005831EFO_0009549N85————11
Genital diseasesD000091662——————11
Neurotoxicity syndromesD020258—G92————11
Sleep wake disordersD012893—G47————11
Liver transplantationD016031EFO_0010682—————11
MorbidityD009017——————11
Organ transplantationD016377——————11
ProteinuriaD011507—R80————11
Hemophilia aD006467EFO_0007267D66————11
Show 5 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
42 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use